Literature DB >> 32596834

Component network meta-analysis compared to a matching method in a disconnected network: A case study.

Gerta Rücker1, Susanne Schmitz2, Guido Schwarzer1.   

Abstract

Network meta-analysis is a method to combine evidence from randomized controlled trials (RCTs) that compare a number of different interventions for a given clinical condition. Usually, this requires a connected network. A possible approach to link a disconnected network is to add evidence from nonrandomized comparisons, using propensity score or matching-adjusted indirect comparisons methods. However, nonrandomized comparisons may be associated with an unclear risk of bias. Schmitz et al. used single-arm observational studies for bridging the gap between two disconnected networks of treatments for multiple myeloma. We present a reanalysis of these data using component network meta-analysis (CNMA) models entirely based on RCTs, utilizing the fact that many of the treatments consisted of common treatment components occurring in both networks. We discuss forward and backward strategies for selecting appropriate CNMA models and compare the results to those obtained by Schmitz et al. using their matching method. CNMA models provided a good fit to the data and led to treatment rankings that were similar, though not fully equal to that obtained by Schmitz et al. We conclude that researchers encountering a disconnected network with treatments in different subnets having common components should consider a CNMA model. Such models, exclusively based on evidence from RCTs, are a promising alternative to matching approaches that require additional evidence from observational studies. CNMA models are implemented in the R package netmeta.
© 2020 The Authors. Biometrical Journal published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  component network meta-analysis; disconnected network; matching; network meta-analysis

Year:  2020        PMID: 32596834     DOI: 10.1002/bimj.201900339

Source DB:  PubMed          Journal:  Biom J        ISSN: 0323-3847            Impact factor:   2.207


  7 in total

Review 1.  A review of the quantitative effectiveness evidence synthesis methods used in public health intervention guidelines.

Authors:  Ellesha A Smith; Nicola J Cooper; Alex J Sutton; Keith R Abrams; Stephanie J Hubbard
Journal:  BMC Public Health       Date:  2021-02-03       Impact factor: 3.295

2.  A review of methods for addressing components of interventions in meta-analysis.

Authors:  Maria Petropoulou; Orestis Efthimiou; Gerta Rücker; Guido Schwarzer; Toshi A Furukawa; Alessandro Pompoli; Huiberdina L Koek; Cinzia Del Giovane; Nicolas Rodondi; Dimitris Mavridis
Journal:  PLoS One       Date:  2021-02-08       Impact factor: 3.240

3.  Joining the Dots: Linking Disconnected Networks of Evidence Using Dose-Response Model-Based Network Meta-Analysis.

Authors:  Hugo Pedder; Sofia Dias; Meg Bennetts; Martin Boucher; Nicky J Welton
Journal:  Med Decis Making       Date:  2021-01-15       Impact factor: 2.583

Review 4.  Low FODMAP Diet and Probiotics in Irritable Bowel Syndrome: A Systematic Review With Network Meta-analysis.

Authors:  Chao-Rong Xie; Bin Tang; Yun-Zhou Shi; Wen-Yan Peng; Kun Ye; Qing-Feng Tao; Shu-Guang Yu; Hui Zheng; Min Chen
Journal:  Front Pharmacol       Date:  2022-03-09       Impact factor: 5.810

5.  Bayesian models for aggregate and individual patient data component network meta-analysis.

Authors:  Orestis Efthimiou; Michael Seo; Eirini Karyotaki; Pim Cuijpers; Toshi A Furukawa; Guido Schwarzer; Gerta Rücker; Dimitris Mavridis
Journal:  Stat Med       Date:  2022-03-08       Impact factor: 2.497

6.  Network Meta-analysis on Disconnected Evidence Networks When Only Aggregate Data Are Available: Modified Methods to Include Disconnected Trials and Single-Arm Studies while Minimizing Bias.

Authors:  Howard Thom; Joy Leahy; Jeroen P Jansen
Journal:  Med Decis Making       Date:  2022-05-07       Impact factor: 2.749

Review 7.  Systematic review and network meta-analysis of the efficacy of existing treatments for patients with recurrent glioblastoma.

Authors:  Anna Schritz; Nassera Aouali; Aurélie Fischer; Coralie Dessenne; Roisin Adams; Guy Berchem; Laetitia Huiart; Susanne Schmitz
Journal:  Neurooncol Adv       Date:  2021-04-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.